Can sequence identifiers be used to discuss parts of a sequence?
Yes, sequence identifiers can be used to discuss or claim parts or fragments of a properly presented sequence. The MPEP provides guidance on this matter: “Sequence identifiers can also be used to discuss and/or claim parts or fragments of a properly presented sequence. For example, language such as ‘residues 14 to 243 of SEQ ID…
Read MoreDo the sequence identifier rules affect 35 U.S.C. 112 requirements?
No, the sequence identifier rules do not alter the requirements of 35 U.S.C. 112. The MPEP clarifies: “The rules do not alter, in any way, the requirements of 35 U.S.C. 112. The implementation of the rules has had no effect on disclosure and/or claiming requirements. The rules, in general, or the use of sequence identifiers…
Read MoreWhat is the requirement for referencing sequences in patent applications?
According to 37 CFR 1.831(c), each nucleotide and/or amino acid sequence set forth in a “Sequence Listing XML” must be referenced by a sequence identifier in the text of the description or claims. The MPEP states: “reference must be made to the sequence by use of the sequence identifier, preceded by ‘SEQ ID NO:’ or…
Read MoreHow should sequences be referenced in patent application drawings?
When sequences are presented in drawings of a patent application, 37 CFR 1.831(c) provides specific guidelines: “Where a sequence is presented in a drawing, reference must be made to the sequence by use of the sequence identifier (ยง 1.832(a)), either in the drawing or in the Brief Description of the Drawings, where the correlation between…
Read More